PARKHOSPS · Healthcare · Medical Care Facilities
Composite scorecard: 50/100 — Quality 86 · Valuation 0
| Share price | ₹279.00 |
| Market cap | ₹12,358 Cr |
| P/E ratio | 41.6 |
| P/B ratio | 5.6 |
| ROE | 16.9% |
| Book value | ₹50.79 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹1,679 Cr | ₹274 Cr | 26.0% |
| 2025 | ₹1,394 Cr | ₹213 Cr | 27.0% |
| 2024 | ₹1,231 Cr | ₹152 Cr | 25.0% |
| 2023 | ₹1,255 Cr | ₹228 Cr | 31.0% |
| 2022 | ₹1,084 Cr | ₹199 Cr | 32.0% |
Park Medi World Limited operates a network of hospitals. The company provides cardiac sciences, neurosciences - brain and spine, plastic and cosmetic surgery, general and laparoscopic surgery, renal sciences and kidney transplant, bone, orthopaedics, joint replacement and sports medicine, gastroenterology and surgical gastroenterology, cancer care, bone marrow transplant, iMARS / robot-assisted surgery. It also offers bariatric surgery, anaesthesiology, critical care, chest and respiratory diseases, dental care, dermatology, endocrinology, paediatrics, internal medicine and geriatrics, rheumat